This is a routine initial filing reflecting pre-IPO ownership structure. Traders should monitor for future Form 4 or Form 144 filings post-IPO for potential selling activity by RTW. The disclosure confirms RTW's significant pre-IPO stake, which may influence post-listing supply dynamics.
Price Chart
Executive Summary
RTW Investments, LP and its Managing Partner Roderick Wong filed a Form 3 disclosing beneficial ownership of 10,276,820 shares of Kailera Therapeutics common stock, underlying Series A and Series B preferred stock held by affiliated funds. The shares will convert into common stock on a 1-for-1 basis prior to KLRA's initial public offering.
Key Facts
- RTW Investments, LP and Roderick Wong filed initial Form 3 for beneficial ownership of securities in Kailera Therapeutics, Inc. (KLRA)
- Reported holdings consist of 8,250,000 shares underlying Series A Preferred Stock and 2,026,820 shares underlying Series B Preferred Stock, totaling 10,276,820 common shares on conversion
- All preferred shares will automatically convert into common stock on a 1-for-1 basis prior to KLRA's IPO
- Roderick Wong is Managing Partner and Chief Investment Officer of RTW Investments, LP
- The filing is an initial ownership disclosure; no transactions are reported
Financial Impact
10,276,820 shares to be converted into common stock upon IPO
Risk Factors
- Potential for future share dilution or selling pressure post-IPO from this large shareholder group
- Lack of liquidity until IPO occurs
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001231919-26-000369 |
| Document: 0001231919-26-000369-index.html | 0001231919-26-000369 |
| Document: 0001231919-26-000369.txt | 0001231919-26-000369 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | 3 | $14.91 $12.92 | ▼ −13.35% | ▼ −12.85% | $10.39 (−30.32%) |
Aug 12, 2026 7w ago | 8-K | $17.97 $17.47 | ▼ −2.78% | ▼ −0.82% | $10.39 (−42.18%) |
Jul 31, 2026 9w ago | Court Ruling | $16.94 $18.66 | ▲ +10.15% | ▲ +6.64% | $10.39 (−38.67%) |
Jul 24, 2026 10w ago | Court Ruling | $17.69 $17.05 | ▼ −3.62% | ▼ −3.99% | $10.39 (−41.27%) |
Jun 5, 2026 16w ago | Press Release | $19.70 $19.67 | ▼ −0.15% | ▼ −2.26% | $10.39 (−47.26%) |
May 26, 2026 18w ago | 8-K | $21.91 $22.38 | ▲ +2.15% | ▲ +1.68% | $10.39 (−52.58%) |
May 26, 2026 18w ago | Press Release | $21.91 $22.59 | ▲ +3.10% | ▲ +1.90% | $10.39 (−52.58%) |
May 13, 2026 20w ago | Press Release | $21.11 $19.62 | ▼ −7.06% | ▼ −5.90% | $10.39 (−50.78%) |
Apr 20, 2026 23w ago | 8-K | $25.22 $23.82 | ▼ −5.55% | ▼ −6.63% | $10.39 (−58.80%) |
Apr 20, 2026 23w ago | Insider Cluster | $24.61 $23.51 | ▼ −4.47% | ▼ −5.38% | $10.39 (−57.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access